The ASCENT Trial: a phase 2 study of induction and consolidation afatinib and chemoradiation with or without surgery in stage III EGFR-mutant NSCLC.

Published in:

Oncologist, 2024, v. 29, n. 7, p. 609, doi. 10.1093/oncolo/oyae107

By:

• Chang, Allison E B;
• Piper-Vallillo, Andrew J;
• Mak, Raymond H;
• Lanuti, Michael;
• Muzikansky, Alona;
• Rotow, Julia;
• Jänne, Pasi A;
• Mino-Kenudson, Mari;
• Swanson, Scott;
• Wright, Cameron D;
• Kozono, David;
• Marcoux, Paul;
• Piotrowska, Zofia;
• Sequist, Lecia V;
• Willers, Henning

Publication type:

Article